CMPX vs TEL · $367.4M cap vs P/E 39, rev $17.26B
Compass Therapeutics Inc. (CMPX) versus TE Connectivity Ltd (TEL) — a side-by-side from cached financials, not a winner call.
Compass Therapeutics Inc. (CMPX) is a biotechnology company listed on US.
TE Connectivity Ltd (TEL) is a electronic components company listed on US.
CMPX does not have a complete income-statement cache yet.
Latest reported TEL revenue for 2025-09-26 was $17.26B. Net income was $1.84B. Revenue was up 8.9% from 2024-09-27 to 2025-09-26. TEL currently screens at market cap $52.52B and trailing P/E 38.5.
CMPX currently screens at market cap $367.4M. TEL currently screens at market cap $52.52B and trailing P/E 38.5.
Not investment advice. Open the CMPX and TEL stock pages for the full models.
Not investment advice.